Dr René Roy, Ph.D.

Dr René Roy, holder of the Canada Research Chair in Medicinal Chemistry, is an renown expert in this domain. He completed his Ph.D. in organic chemistry at Université de Montréal before going on to work at the National Research Council’s Institute for Biological Sciences in Ottawa. He then joined the Department of Chemistry at the University of Ottawa. He returned to Montréal to work at the Université du Québec à Montréal. Dr Roy uses modern organic chemistry to study how neoglycoconjugates and polymers can be developed and used to combat diseases related to glycoproteins. His innovations in glycan structures (such as glycopolymers and glycodendrimers) have shed light on multivalent molecular recognition mechanisms.

René Roy medicinal chemistry

Dr Roy was also the founder and Director of UQAM’s PharmaQÀM research group, consisting of some 50 professors of 17 universities with shared interests in pharmaceutical research. He is the author of more than 340 publications (including many speciality sections) and editor of two books on vaccines and glycomimetics.

Dr Roy benefits of previous experience in holding patents, having a record of 4 current patents, among which three having achieved significant commercial success.  He is the co-creator of the first semi-synthetic vaccine against bacterial meningitis.  That vaccine has saved millions of children lives in several countries in the world. Dr Roy was also a professional advisor to large international pharmaceutical companies.

Honors and awards

  • Hoffmann-LaRoche award for his contribution to medicinal chemistry.
  • University of Ottawa Science Faculty’s «Researcher of the Year».
  • Ottawa Life Sciences Council Achievement Award and Rotary International Paul Harris Fellowship for his work on the first synthetic vaccine against H. influenza type B (Hib), work carried out with Cuban researchers.
  • National Research Council Royalty Sharing Award for his work on the meningitis C vaccine.
  • Melville L. Wolfrom award from the ACS Division of Carbohydrate Chemistry for his contributions to glycochemistry.
  • He and his Cuban colleagues received the Tech Museum Award—Technology Benefiting Humanity for their work on the Hib vaccine, today used in the Cuban public health service.
  • Distinction for the discovery of the year by the Quebec Sciences magazine.
  • He was chosen as the 30th annual Probst Memorial Lecturer by the Southern Illinois University for his work on vaccines for children in developing nations.
  • Received a Gold Medal from the World Intellectual Property Organization (WIPO) for the QuimiHib vaccine.
  • He was named “Personality of the Week” by Montréal daily La Presse .
  • Nominee of the «Cercle d’excellence» of the Université du Québec.
Awards nanomedicine